These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36413539)

  • 21. Artificial Pancreas Technology Offers Hope for Childhood Diabetes.
    Schoelwer MJ; DeBoer MD
    Curr Nutr Rep; 2021 Mar; 10(1):47-57. PubMed ID: 33411096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption.
    Aaron RE; Tian T; Yeung AM; Huang J; Arreaza-Rubín GA; Ginsberg BH; Kompala T; Lee WA; Kerr D; Colmegna P; Mendez CE; Muchmore DB; Wallia A; Klonoff DC
    J Diabetes Sci Technol; 2024 Jan; 18(1):215-239. PubMed ID: 37811866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms.
    Armiger R; Reddy M; Oliver NS; Georgiou P; Herrero P
    J Diabetes Sci Technol; 2022 Jan; 16(1):29-39. PubMed ID: 34861785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New closed-loop insulin systems.
    Boughton CK; Hovorka R
    Diabetologia; 2021 May; 64(5):1007-1015. PubMed ID: 33550442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New technologies in diabetes treatment].
    Serfling G; Kalscheuer H; Schmid SM; Lehnert H
    Internist (Berl); 2019 Sep; 60(9):912-916. PubMed ID: 31375851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
    Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Closed-loop insulin delivery: update on the state of the field and emerging technologies.
    Ware J; Hovorka R
    Expert Rev Med Devices; 2022 Nov; 19(11):859-875. PubMed ID: 36331211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.
    Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M
    J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas.
    Ang KH; Tamborlane WV; Weinzimer SA
    Expert Opin Drug Deliv; 2015; 12(10):1579-82. PubMed ID: 26389567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems.
    Sun X; Rashid M; Hobbs N; Brandt R; Askari MR; Cinar A
    J Diabetes Sci Technol; 2022 Jan; 16(1):19-28. PubMed ID: 34861777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strengths and Challenges of Closed-Loop Insulin Delivery During Exercise in People With Type 1 Diabetes: Potential Future Directions.
    Paldus B; Morrison D; Lee M; Zaharieva DP; Riddell MC; O'Neal DN
    J Diabetes Sci Technol; 2023 Jul; 17(4):1077-1084. PubMed ID: 35466723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.